Enliven Therapeutics Cash Flow Statement (2019-2026) | ELVN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-13.12M	-13.63M	-14.26M	-8.67M	-8.89M	-10.55M	-9.55M	-14.72M	-16.72M	-20.76M	-19.36M	-22.74M	-20.75M	-23.23M	-23.18M	-28.50M	-25.33M	-20.15M	68.22M	-23.63M
Depreciation and Depletion (Quarter)	0.03M	0.02M	0.03M	0.04M	0.40M	0.06M	0.06M	0.07M	0.07M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.07M	0.08M	0.06M	0.05M	0.01M
Share-based Compensation (Quarter)	0.92M	1.00M	0.98M	0.65M	0.70M	1.10M	0.73M	2.26M	4.20M	3.40M	3.06M	4.51M	5.14M	5.18M	5.34M	6.80M	7.72M	7.18M	12.31M	7.40M
Gains from Sales and Divestitures (Quarter)								0.01M	0.02M	0.01M	0.01M	0.00M	0.00M	0.01M	0.02M	0.01M	0.02M	0.02M	0.03M	0.01M
Gains from Investment Securities (Quarter)	0.27M	0.86M	3.08M	1.89M	0.50M	1.83M		3.89M	2.17M	5.95M		7.76M	7.46M	2.32M	3.97M	2.47M	3.72M	3.68M	4.56M	1.92M
Non-cash Items (Quarter)	3.83M	0.25M	9.66M	0.22M	0.01M	0.26M	1.19M				35.69M				69.19M				5.01M
Cash from Operations (Quarter)	-10.37M	-10.90M	-12.48M	-10.36M	-7.12M	-6.45M	-8.14M	-20.84M	-12.05M	-15.89M	-12.48M	-23.36M	-20.43M	-12.19M	-17.20M	-24.13M	-17.06M	-13.28M	-15.84M	-19.29M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.03M	-0.02M	-0.05M	-0.05M	0.05M				0.83M	1.98M	1.79M	0.66M	0.60M	-0.71M	-0.98M	0.04M	-0.07M	0.31M	-0.06M	-0.27M
Depreciation & Amortization (CF) (Quarter)	0.03M	0.02M	0.03M	39.00M	0.05M	0.06M	0.05M	0.07M	0.07M	0.08M	0.08M	0.08M	0.08M	0.08M	0.06M	0.07M	0.08M	0.06M	0.08M	0.01M
Change in Working Capital
Change in Account Payables (Quarter)	-0.38M	-0.15M	-0.12M	-1.56M	0.59M	1.36M	0.02M	0.49M	-0.19M	-1.59M	-0.96M	2.15M	-1.60M	-0.06M	0.32M	0.22M	0.79M	-1.02M	0.83M	-0.52M
Change in Accured Expenses (Quarter)	2.02M	0.43M	0.16M	-0.29M	0.85M	0.39M	0.66M	-2.85M	1.10M	4.64M	4.78M	-3.06M	-0.25M	4.35M	-1.28M	-2.50M	0.01M	0.81M	1.18M	-4.46M
Investing Activities
Capital Expenditures (Quarter)				0.19M	0.30M	0.01M	0.10M	0.03M	-0.03M	0.14M	0.01M	0.02M	0.00M	0.02M		0.02M	-0.02M	0.16M
Change in Acquisitions & Divestments (Quarter)	7.20M	13.40M	3.30M	5.47M	6.48M	-11.95M				40.00M	80.00M	38.91M	77.17M	80.59M	117.24M	60.67M	56.74M	67.80M	87.69M	108.36M
Cash from Investing Activities (Quarter)	3.39M	-8.83M	-14.49M	-0.19M	-0.30M	-0.01M	-0.10M	-0.03M	-151.52M	-35.55M	38.69M	-17.89M	-33.66M	14.83M	0.73M	1.43M	-183.59M	-4.06M	12.38M	42.53M
Financing Activities
Other financing activities (Quarter)																			0.10M
Change in Capital Stock
Shares Issued (Quarter)	0.24M	0.14M		0.57M	0.01M	-0.58M	0.59M	162.90M	-1.53M	-161.06M	0.09M	0.27M	1.79M	1.12M	0.45M	0.23M	1.32M	0.21M	0.53M	10.05M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	1.66M	46.99M	-0.01M	0.41M	0.01M	0.16M	-2.38M	237.44M	-2.82M	-0.42M	0.09M	90.27M	1.81M	1.12M	39.97M	0.23M	218.38M	-0.37M	0.62M	10.05M
Change in Cash (Quarter)	-5.32M	27.26M	-26.99M	-10.15M	-7.42M	-6.30M	-10.62M	216.57M	-166.39M	-51.87M	26.29M	49.02M	-52.29M	3.75M	23.50M	-22.47M	17.73M	-17.70M	-2.84M	33.29M
Free Cash Flow (Quarter)	-10.37M	-10.90M	-12.48M	-10.55M	-7.43M	-6.46M	-8.25M	-20.88M	-12.02M	-16.03M	-12.50M	-23.38M	-20.44M	-12.21M	-17.20M	-24.15M	-17.04M	-13.44M	-15.84M	-19.29M
Net Cash Flow (Quarter)	-5.32M	27.26M	-26.99M	-10.15M	-7.42M	-6.30M	-10.62M	216.57M	-166.39M	-51.87M	26.29M	49.02M	-52.29M	3.75M	23.50M	-22.47M	17.73M	-17.70M	-2.84M	33.29M

Research Tools

Developers

Enliven Therapeutics Cash Flow Statement (2019-2026) | ELVN

Research Tools

Developers

Enliven Therapeutics Cash Flow Statement (2019-2026) | ELVN

Create an account

Sign In

Reset Password